ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding ImageneBio, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 48 | 1 | 46 | −1 |
| Shares | 27.5M | 3.45K | 26.8M | −700.5K (−2.5%) |
| Value | $167.8M | $21.0K | $118.7M | −$49.1M (−29.3%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held ImageneBio, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Verition Fund Management LLC | 1,021,890 | $4.53M | 0.10% |
| Laurion Capital Management LP | 529,000 | $2.34M | 0.10% |
| Millennium Management LLC | 235,818 | $1.04M | 0.00% |
| Oasis Management Co Ltd. | 140,000 | $620.0K | 0.11% |
| Ergoteles LLC | 116,041 | $514.0K | 0.02% |
| Jacobs Levy Equity Management, Inc | 40,915 | $181.0K | 0.00% |
| Cornercap Investment Counsel Inc | 16,636 | $74.0K | 0.01% |
| Virtu Financial LLC | 15,544 | $69.0K | 0.01% |
| Bridgeway Capital Management, LLC | 13,000 | $58.0K | 0.00% |
| Dimensional Fund Advisors LP | 10,132 | $45.0K | 0.00% |
| Acadian Asset Management LLC | 10,198 | $45.0K | 0.00% |
| Private Capital Group, LLC | 252 | $1.00K | 0.00% |
| Credit Suisse AG | 15 | $0 | 0.00% |
| Capital Advisors, Ltd. LLC | 27 | $0 | 0.00% |
Sold out (15)
Institutions that held ImageneBio, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Logos Global Management LP | 178,281 | $1.09M |
| Nuveen Asset Management, LLC | 74,108 | $540.0K |
| Bank of New York Mellon Corp | 76,483 | $466.0K |
| Charles Schwab Investment Management Inc | 66,810 | $408.0K |
| Rhumbline Advisers | 28,768 | $175.0K |
| Deutsche Bank AG | 15,058 | $92.0K |
| American International Group, Inc. | 13,758 | $84.0K |
| Manufacturers Life Insurance Company, The | 12,479 | $76.1K |
| California State Teachers Retirement System | 11,895 | $73.0K |
| Voya Investment Management LLC | 11,117 | $68.0K |
| Nisa Investment Advisors, LLC | 8,000 | $49.0K |
| Amalgamated Bank | 3,451 | $21.0K |
| Legal & General Group Plc | 2,273 | $14.0K |
| Ameritas Investment Partners, Inc. | 2,142 | $13.0K |
| Point72 Hong Kong Ltd | 594 | $4.00K |
Not filed for Q2 2022 yet (1)
Institutions that held ImageneBio, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 3,451 | $21.0K |